Heberprot-P Plus®
Enhanced recombinant human epidermal growth factor (rh-EGF) therapy for complex diabetic foot ulcers, with adjunctive wound-care support.
Product information
Heberprot-P Plus — an enhanced rh-EGF intralesional therapy from CIGB, Havana, with adjunctive wound-care support.
Indications
Complex diabetic foot ulcers (Wagner grade 2–4) requiring enhanced growth-factor therapy.
Formulation
Injectable enhanced rh-EGF solution with adjunctive wound-care coordination.
Administration
Intralesional injection by trained wound-care specialists, with coordinated wound-care program.
Precautions
Contraindicated in hypersensitivity to EGF. Must be administered by trained personnel with debridement and off-loading.
Product information
- Manufacturer
- CIGB, Havana
- Regulatory status
- Registered in Cuba; export authorization
Diabetic Foot & Wound Healing
Heberprot-P®
Recombinant human epidermal growth factor (rh-EGF) for complex diabetic foot ulcers — Cuba's flagship wound-healing biotech.
Hebermin®
Topical wound-healing product supporting granulation and epithelialization of chronic wounds.
Advanced Wound Dressings
Medical-grade advanced wound dressings supporting granulation and healing.